Increase of classical antiepileptic drug utilization in Croatia during the process of introducing the new generation of drugs

Collegium Antropologicum

Volumn 27, Issue 2, 2003, Pages 617-621

  Bielen, Ivan ^a   Cvitanović Šojat, Ljerka ^b   Matek, Petar ^a   Planjar Prvan, Miljenka ^a  

^a University Hospital Sveti Duh   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Drug utilization; Epilepsy; Therapy

Indexed keywords

ANTICONVULSIVE AGENT;

ARTICLE; AWARENESS; DATA ANALYSIS; DRUG INFORMATION; DRUG PREFERENCE; DRUG USE; DRUG UTILIZATION; EDUCATION PROGRAM; PATIENT EDUCATION; SYMPTOMATIC EPILEPSY; CROATIA; EPILEPSY; HUMAN;

ANTICONVULSANTS; CROATIA; DRUG UTILIZATION; EPILEPSY; HUMANS;

EID: 4344700833     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. DECKERS, C. L. P., P. GENTON, G. J. SILLS, D. SCHMIDT, Epilepsy Res., 53 (2003) 1.
2. WHO COLLABORATING CENTRE FOR DRUG STATISTICS METHODOLOGY: ATC/DDD index 2003. (http://www.whocc.no/atcddd/).
3. CROATIAN BUREAU OF STATISTICS: Statistical yearbook of the Republic of Croatia 2002. (Croatian Bureau of Statistics, Zagreb, 2002).
4. SHORVON, S. D., P. J. FARMER, Epilepsia, 25 Suppl. 1 (1988) 36.
5. KALE, R., Epilepsia, 43 Suppl. (2002) 31.
6. PATSALOS, P. N., J. W. SANDER, Drug Saf., 11 (1994) 37.
7. BRUNBECH, L., A. SABERS, Drugs, 62 (2002) 593.
8. TALIS, R., P. BOON, E. PERUCCA, L. STEPHEN, Epileptic Disord., 4 Suppl. 2 (2002) 33.
9. GRAVES, N. M., Epilepsia, 36 Suppl. 2 (1995) 17.
10. PERUCCA, E., Epilepsia, 40 Suppl. 9 (1999) 7.
11. PERUCCA, E., Clin. Pharmacokinet., 3 (2000) 191.
12. JOHANNESSEN, S. I., D. BATTINO, D. J. BERRY, M. BIALER, G. KRAEMER, T. TORBJORN, P. N. PATSALOS, Ther. Drug Monit., 25 (2003) 1.
13. FOLETTI, G. B., Rev. Med. Suisse. Romande, 9 (2002) 703.
14. SACHDEO, R. C., T. A. GLAUSER, F. RITTER, P. LIM, G. PLEDER, Neurology, 52 (1999) 1882.
15. WALLACE, S. J., Epilepsia, 29 (1998) 147.
16. APPLETON, R. E., A. C. PETERS, J. P. MUMFORD, D. E. SHAW, Epilepsia, 40 (1999) 1627.
17. FOLETTI, G., M. G. DELISLE, D. CHARDON, D. VOLANSCHI, Epilepsia, 40 Suppl. 2 (1999) 166.
18. BRODIE, M., J. FRENCH, Lancet, 356 (2000) 323.
19. GENTON, P., P. GELISSE, Epil. Disord., 2 (2000) 209.
20. JAMBAQUE, I., C. CHIRON, C. DUMAS, J. MUMFORD, O. DULAC, Epilepsy Res., 2-3 (2000) 151.
21. MITCHELL, W. G., N. S. SHAH, Pediatr. Neurol., 3 (2002) 161.
22. HEANEY, D. C., S. D. SHORVON, J. W. SANDER, P. BOON, V. KOMAREK, V. MARUSIC, C. DRAVET, E. PERUCCA, J. MAJKOWSKI, J. L. LIMA, S. ARROYO, T. TOMSON, C. RIED S. VAN DONSELAAR, E. ESKAZAN, P. PEETERS, P. CARITA, I. TJONG-A-HUNG, E. MYON, C. TAIEB, Epilepsia, 41 Suppl. 5 (2000) 37.
23. SHORVON, S. D., General principles of treatment. In: Handbook of epilpsy treatment. (Blackwell Science, Oxford, 2000).
24. LEVY, P. Epilepsia, 43 (2002) 550.
25. BANFI, R., G. BORSELLI, C. MARINAI, A. BORGHERESI, A. CAVALIERI, Pharm. World Sci., 17 (1995) 138.
26. MAGRINI, D., T. EINARSON, A. VACCHERI, P. McMANUS, N. MONTANARO, U. BERGMAN, Eur. Clin. Pharmacol., 53 (1997) 185.
27. NATSCH, S., Y. A. HECHSTER, R. DE YONG, E. R. HEERDINK, R. M. HERINGS, J. W. VAN DER MEER, Eur. J. Clin. Microbiol. Infect. Dis., 17 (1998) 20.